Today's deal net contains news from PGDx, Notch Therapeutics, Quell Therapeutics, SpyBiotech, Vision Medicals, Future Meat Technologies, BusUp and Advanced Chemotherapy Technologies.

The WuXi AppTec-backed round will help the hepatitis B drug developer begin human trials for its lead drug candidate.

China Merchants Group participated in a series C-plus round for the cancer and inflammatory disease drug developer.

Wanxiang's HashKey Capital vehicle is among the backers for the blockchain accelerator's venture capital fund.

The chemicals and materials conglomerate’s regional vehicle will back IoT and automotive startups in China, having already committed to a local growth fund.

Adways, Fidelity, Nissay Capital, Opt, SMBC Venture Capital and Voyage Ventures are all set to exit the C2C skills marketplace operator in an offering on TSE’s Mothers Market.

Several automotive manufacturers backed a series C3 round taking the AI chip developer's funding to $900m in the past two months.

SoftBank will exit social video app developer Hyperconnect roughly six years after it took part in an $8.6m series A round.

Oko Markets was among the backers in a $1.9m close of the logistics technology developer’s series B round, which already included Emtek, EV Growth and SoftBank Ventures Asia.

Today's deal net contains news from Boston Metal, Evologic Therapeutics, Lilz, GaitQ, Hemerion Therapeutics and Rebrain.